Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an update.
Panacea Biotec Limited announced the completion of Mr. Narotam Kumar Juneja’s tenure as a non-executive non-independent director and Whole-time Director of its subsidiary, Panacea Biotec Pharma Limited, as of March 31, 2025. The company expressed gratitude for his contributions to its growth, indicating a period of transition in its leadership structure.
More about Panacea Biotec Limited
Panacea Biotec Limited is a pharmaceutical and biotechnology company based in India. It focuses on developing and manufacturing vaccines, pharmaceuticals, and biosimilars, catering to both domestic and international markets.
YTD Price Performance: 0.49%
Average Trading Volume: 22,748
Current Market Cap: 26.99B INR
See more insights into PANACEABIO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue